loadpatents
name:-0.024616003036499
name:-0.016568899154663
name:-0.0059289932250977
Giaccia; Amato J. Patent Filings

Giaccia; Amato J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Giaccia; Amato J..The latest application filed is for "hypoxia targeting compositions and combinations thereof with a parp inhibitor and methods of use thereof".

Company Profile
5.16.25
  • Giaccia; Amato J. - Stanford CA
  • Giaccia; Amato J. - Palo Alto CA US
  • - Stanford CA US
  • Giaccia, Amato J - Stanford CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Hypoxia Targeting Compositions and Combinations Thereof with a PARP Inhibitor and Methods of Use Thereof
App 20220249522 - Mehibel; Manal ;   et al.
2022-08-11
Receptor-based antagonists of the programmed cell death 1 (PD-1) pathway
Grant 11,400,133 - Giaccia , et al. August 2, 2
2022-08-02
Modified AXL Peptides and Their Use in Inhibition of AXL Signaling in Anti-Metastatic Therapy
App 20220220458 - Giaccia; Amato J. ;   et al.
2022-07-14
Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapy
Grant 11,136,563 - Giaccia , et al. October 5, 2
2021-10-05
Antifibrotic activity of GAS6 inhibitor
Grant 10,876,176 - Tabibiazar , et al. December 29, 2
2020-12-29
Receptor-based Antagonists Of The Programmed Cell Death 1 (pd-1) Pathway
App 20200360474 - Giaccia; Amato J. ;   et al.
2020-11-19
sPD-1 VARIANT - FC FUSION PROTEINS
App 20200181231 - Giaccia; Amato J. ;   et al.
2020-06-11
Receptor-based antagonists of the programmed cell death 1 (PD-1) pathway
Grant 10,588,938 - Giaccia , et al.
2020-03-17
Modulation Of Axl Receptor Activity In Combination With Cytoreductive Therapy
App 20180140679 - Giaccia; Amato J. ;   et al.
2018-05-24
Receptor-Based Antagonists of the Programmed Cell Death 1 (PD-1) Pathway
App 20180125934 - Giaccia; Amato J. ;   et al.
2018-05-10
Inhibition Of Axl/gas6 Signaling In The Treatment Of Liver Fibrosis
App 20180094034 - O'Connor; Patrick ;   et al.
2018-04-05
Antifibrotic Activity Of Gas6 Inhibitor
App 20180057898 - Tabibiazar; Raymond ;   et al.
2018-03-01
Modified Axl Peptides And Their Use In Inhibition Of Axl Signaling In Anti-metastatic Therapy
App 20180030422 - Giaccia; Amato J. ;   et al.
2018-02-01
Inhibition of AXL/GAS6 signaling in the treatment of liver fibrosis
Grant 9,879,061 - O'Connor , et al. January 30, 2
2018-01-30
Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapy
Grant 9,822,347 - Giaccia , et al. November 21, 2
2017-11-21
High-affinity Binding To Gas6
App 20160266136 - Cochran; Jennifer R. ;   et al.
2016-09-15
Inhibition of AXL Signaling in Anti-Metastatic Therapy
App 20160108378 - Giaccia; Amato J. ;   et al.
2016-04-21
Inhibition of AXL signaling in anti-metastatic therapy
Grant 9,266,947 - Giaccia , et al. February 23, 2
2016-02-23
Modified AXL Peptides and Their Use in Inhibition of AXL Signaling in Anti-Metastatic Therapy
App 20150315553 - Giaccia; Amato J. ;   et al.
2015-11-05
Inhibition of AXL Signaling in Primary Tumor Therapy
App 20150315552 - Giaccia; Amato J. ;   et al.
2015-11-05
Inhibition of AXL signaling in anti-metastatic therapy
Grant 9,074,192 - Giaccia , et al. July 7, 2
2015-07-07
ShRNA gene therapy for treatment of ischemic heart disease
Grant 8,680,064 - Wu , et al. March 25, 2
2014-03-25
Inhibition of AXL Signaling in Anti-Metastatic Therapy
App 20140065143 - Giaccia; Amato J. ;   et al.
2014-03-06
Inhibition of AXL signaling in anti-metastatic therapy
Grant 08618254 -
2013-12-31
Inhibition of AXL signaling in anti-metastatic therapy
Grant 8,618,254 - Giaccia , et al. December 31, 2
2013-12-31
Promoting Erythropoietin, Erythrocyte, and Hematopoietic Stem Cell Production By Activating HIF In OsteoBlasts
App 20130196907 - Rankin; Erinn Bruno ;   et al.
2013-08-01
Inhibition of AXL/GAS6 Signaling in the Treatment of Disease
App 20130189254 - O'Connor; Patrick ;   et al.
2013-07-25
Inhibition of AXL Signaling in Anti-Metastatic Therapy
App 20130108644 - Giaccia; Amato J. ;   et al.
2013-05-02
Inhibition of AXL Signaling in Anti-Metastatic Therapy
App 20130017205 - Giaccia; Amato J. ;   et al.
2013-01-17
Heteroaryl Benzamides, Compositions And Methods Of Use
App 20120225862 - Sutphin; Patrick D. ;   et al.
2012-09-06
Heteroaryl Compounds, Compositions, And Methods Of Use In Cancer Treatment
App 20110105436 - Turcotte; Sandra ;   et al.
2011-05-05
Methods and compositions for regulating adipogenesis
Grant 7,378,246 - Giaccia , et al. May 27, 2
2008-05-27
Anaerobe targeted enzyme-mediated prodrug therapy
Grant 6,984,513 - Brown , et al. January 10, 2
2006-01-10
Methods and compositions for regulating adipogenesis
App 20050282167 - Giaccia, Amato J ;   et al.
2005-12-22
Anaerobe targeted enzyme-mediated prodrug therapy
App 20030103952 - Brown, John M. ;   et al.
2003-06-05
Diagnostic marker for tumor hypoxia and prognosis
App 20030044862 - Giaccia, Amato J. ;   et al.
2003-03-06
Tumor treatment method
Grant 5,646,185 - Giaccia , et al. July 8, 1
1997-07-08
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed